Jefferies Initiates Spectrum Pharmaceuticals With Hold

Analysts at Jefferies initiated coverage on Spectrum Pharmaceuticals SPPI with a Hold rating. The target price for Spectrum Pharmaceuticals is set to $8. Spectrum Pharmaceuticals shares have dropped 20.96% over the past 52 weeks, while the S&P 500 index has surged 15.18% in the same period. Spectrum Pharmaceuticals' shares rose 0.40% to $7.42 in after-hours trading.